Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion

被引:0
作者
Kevin F. Bieniek
Melissa E. Murray
Nicola J. Rutherford
Monica Castanedes-Casey
Mariely DeJesus-Hernandez
Amanda M. Liesinger
Matthew C. Baker
Kevin B. Boylan
Rosa Rademakers
Dennis W. Dickson
机构
[1] Mayo Clinic,Department of Neuroscience
[2] Mayo Clinic,Department of Neurology
来源
Acta Neuropathologica | 2013年 / 125卷
关键词
Frontotemporal lobar degeneration; C9ORF72; Ubiquitin; P62; Ubiquilin-2; Tau;
D O I
暂无
中图分类号
学科分类号
摘要
An expanded GGGGCC hexanucleotide repeat in C9ORF72 is the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal lobar degeneration associated with TDP-43 pathology (FTLD-TDP). In addition to TDP-43-positive neuronal and glial inclusions, C9ORF72-linked FTLD-TDP has characteristic TDP-43-negative neuronal cytoplasmic and intranuclear inclusions as well as dystrophic neurites in the hippocampus and cerebellum. These lesions are immunopositive for ubiquitin and ubiquitin-binding proteins, such as sequestosome-1/p62 and ubiquilin-2. Studies examining the frequency of the C9ORF72 mutation in clinically probable Alzheimer’s disease (AD) have found a small proportion of AD cases with the mutation. This prompted us to systematically explore the frequency of Alzheimer-type pathology in a series of 17 FTLD-TDP cases with mutations in C9ORF72 (FTLD-C9ORF72). We identified four cases with sufficient Alzheimer-type pathology to meet criteria for intermediate-to-high-likelihood AD. We compared AD pathology in the 17 FTLD-C9ORF72 to 13 cases of FTLD-TDP linked to mutations in the gene for progranulin (FTLD-GRN) and 36 cases of sporadic FTLD (sFTLD). FTLD-C9ORF72 cases had higher Braak neurofibrillary tangle stage than FTLD-GRN. Increased tau pathology in FTLD-C9ORF72 was assessed with thioflavin-S fluorescent microscopy-based neurofibrillary tangle counts and with image analysis of tau burden in temporal cortex and hippocampus. FTLD-C9ORF72 had significantly more neurofibrillary tangles and higher tau burden compared with FTLD-GRN. The differences were most marked in limbic regions. On the other hand, sFTLD and FTLD-C9ORF72 had a similar burden of tau pathology. These results suggest FTLD-C9ORF72 has increased propensity for tau pathology compared to FTLD-GRN, but not sFTLD. The accumulation of tau as well as lesions immunoreactive for ubiquitin and ubiquitin-binding proteins (p62 and ubiquilin-2) suggests that mutations in C9ORF72 may involve disrupted protein degradation that favors accumulation of multiple different proteins.
引用
收藏
页码:289 / 302
页数:13
相关论文
共 160 条
[1]  
Al-Sarraj S(2011)p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS Acta Neuropathol 122 691-702
[2]  
King A(2007)TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer’s disease Ann Neurol 61 435-445
[3]  
Troakes C(2009)Phosphorylated TDP-43 in Alzheimer’s disease and dementia with Lewy bodies Acta Neuropathol 117 125-136
[4]  
Amador-Ortiz C(2005)Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation J Neurochem 94 192-203
[5]  
Lin WL(2007)Neuropathologic heterogeneity in HDDD1: a familial frontotemporal lobar degeneration with ubiquitin-positive inclusions and progranulin mutation Alzheimer Dis Assoc Disord 21 1-7
[6]  
Ahmed Z(2012)Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 Brain 135 765-783
[7]  
Arai T(1991)Neuropathological staging of Alzheimer-related changes Acta Neuropathol 82 239-259
[8]  
Mackenzie IR(2012)Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion Acta Neuropathol 123 825-839
[9]  
Hasegawa M(2007)Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration Acta Neuropathol 114 5-22
[10]  
Babu JR(2001)Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation Nat Cell Biol 3 740-744